Effect of clozapine on immunoglobulin M plasma levels
Resumen: Clozapine is an atypical antipsychotic medication indicated for the treatment of patients who fail to respond to standard antipsychotic treatment. It possesses immunomodulatory properties and requires regular counts of white blood cells and absolute neutrophils. It has been reported to mediate several effects on humoral immunity, such as altering the levels of antibody-producing cytokines [Hinze-Selch et al. 1998].
Selective immunoglobulin M immunodeficiency (SIgMD) is a rare form of dysgammaglobulinaemia characterized by a selective, low level of immunoglobulin M (IgM) in conjunction with normal T cell numbers and function, and with no other identifiable immunodeficiencies. It can occur as either a primary or secondary condition and displays an estimated prevalence of 0.03%– 3%. Secondary SIgMD can be associated with malignancy, autoimmune disorders, gastrointestinal diseases and/or immunosuppressive treatments [Goldstein et al. 2006]...

Idioma: Inglés
DOI: 10.1177/2045125315591925
Año: 2016
Publicado en: THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY 6, 1 (2016), 58-60
ISSN: 2045-1253

Tipo y forma: (Published version)
Exportado de SIDERAL (2018-05-23-14:35:20)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
articulos



 Notice créée le 2018-05-23, modifiée le 2019-02-20


Versión publicada:
 PDF
Évaluer ce document:

Rate this document:
1
2
3
 
(Pas encore évalué)